Behavioral Therapy Development for Methamphetamine Abusers

Inclusion Criteria: 1. HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 18-65 2. Willing to give informed consent and comply with study procedures; 3. Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications; 4. Diagnosed with current methamphetamine abuse as determined by MINI; and 5. Interested in seeking treatment for their methamphetamine abuse and in participating in this research project. Exclusion Criteria: 1. Unwilling to give, or withdrawal of, informed consent; 2. Inability to understand nature of study; 3. A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria for current bipolar disorder or a psychotic disorder); 4. Current suicidal ideation or suicide attempt within the past 3 months; and 5. Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI. 6. Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.